Researchers use focused ultrasound to safely and non-invasively open the blood-brain barrier in Alzheimer's patients.
According to a new study, a drug used to treat multiple sclerosis could help to treat pain caused by cancer treatments in myeloma patients.
A new study implicates the basolateral amygdala in conditioned taste aversion. The study could pave the way for treatments to curb taste aversions associated with chemotherapy and eating disorders.
An inhibitor of the 20-HETE chemical has been used to successfully control the spread and growth of human glioblastoma and breast cancer in lab models of the diseases, researchers report.
Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.
A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
Dronabinol, a drug that contains a synthetic version of the molecule tetrahydrocannabinol, appears to be both safe and effective in treating obstructive sleep apnea, a new study reports.
A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.
Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.
Researchers are turning to supercomputers in the quest to discover new treatments and targets for cancers.
Temozolomide, a chemotherapy drug used to treat brain cancer, could increase risks of developing depression by preventing neurogenesis, a new study reports.
Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.
